Exane Derivatives’s Trupanion TRUP Stock Holding History
Bought
Maintained
Sold
Other funds holding TRUP
NTCM
AI
Exane Derivatives's TRUP Position: Q2 2022 in Review
Exane Derivatives sold out of Trupanion (TRUP) in Q2 2022, closing a stake of 1,126 shares — an estimated $100K sold.
Exane Derivatives first reported a position in TRUP in Q4 2020 and held it in 5 quarters. The position peaked at $463K in Q4 2020. 209 funds tracked by Wall St. Rank hold TRUP as of Q2 2022.
- Exane Derivatives reported no remaining Trupanion position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 1,126 Trupanion shares in Q2 2022, an estimated $100K.
- Exane Derivatives first reported a position in Trupanion in Q4 2020 and held it in 5 quarters.
- Exane Derivatives's Trupanion position peaked at $463K in Q4 2020.
- 209 funds tracked by Wall St. Rank held Trupanion as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.